Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the public purse of rebuilding Whipps Cross Hospital; and what his expected timetable is for when this funding will be made available to Barts Health NHS Trust.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government recognises the immediate issues affecting the National Health Service and is determined to fix them. We also recognise the need for investment in our estate across the country, including at Whipps Cross University Hospital, North East London.
My Rt. Hon. Friend, the Secretary of State for Health and Social Care, has asked for an urgent report on the degree to which the New Hospital Programme is funded and a realistic timetable for delivery. He will consider this carefully then report back to patients, clinicians and local communities to confirm revision, if any, to the schedule.
Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that patients taking pancreatic enzymes continue to receive them.
Answered by Andrew Stephenson
We are aware of supply issues with three pancreatic enzyme replacement therapies: Creon 10000 gastro-resistant capsules; Creon 25000 gastro-resistant capsules; and Nutrizym 22 gastro-resistant capsules. We understand that these are due to limited availability of active pharmaceutical ingredients, and manufacturing constraints in producing the volumes required to meet demand. The Department has issued guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products, to ask that they expedite deliveries and increase production forecasts, and to confirm that they are taking action to address the root causes of the issues, to ensure continuity of supply. We are also working with specialist importers to source unlicensed imports from abroad.
Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.
Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many patients were (a) seen and (b) treated by NHS commissioned Sexual Assault Referral Centres run by Mountain Healthcare in each financial year since 2018-19.
Answered by Maria Caulfield
The following table shows the number of patients were seen by National Health Service-commissioned sexual assault referral centres (SARCs) run by Mountain Healthcare in each financial year since 2018/19:
Year | Number of patients seen |
2018/19 | 4,689 |
2019/20 | 3,240 |
2020/21 | 2,080 |
2021/22 | 3,742 |
2022/23 | 10,822 |
Source: NHS England
Notes:
Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many patients were (a) seen and (b) treated by NHS commissioned Sexual Assault Referral Centres in each financial year since 2018-19.
Answered by Maria Caulfield
The following table shows the numbers of patients seen by National Health Service-commissioned sexual assault referral centres (SARCs) in each financial year since 2018/19:
Year | Number of patients seen by SARCs |
2018/19 | 11,993 |
2019/20 | 9,451 |
2020/21 | 7,960 |
2021/22 | 10,333 |
2022/23 | 21,836 |
Source: NHS England
Notes:
Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many patients were (a) seen and (b) treated by NHS commissioned Sexual Assault Referral Centres run by G4S Health Services in each financial year since 2018-19.
Answered by Maria Caulfield
The following table shows the number of patients seen by National Health Service-commissioned sexual assault referral centres (SARCs) run by G4S Health Services in each financial year since 2018/19:
Year | Number of patients seen |
2018/19 | 1,728 |
2019/20 | 1,256 |
2020/21 | 1,479 |
2021/22 | 1,439 |
2022/23 | 1,625 |
Source: NHS England
Notes:
Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much NHS England paid to (a) Mountain Healthcare Ltd and (b) G4S Health UK Ltd for the provision of healthcare in police custody and secure environments between (i) October 2020 to September 2021 and (ii) October 2021 to September 2022.
Answered by Maria Caulfield
NHS England does not have responsibility for healthcare provision within police custody, as this sits with police commissioners and the Home Office.
Regarding payments to Mountain Healthcare Ltd and G4S Health UK Ltd for provision within the detained estate, NHS England has advised that figures are not available of the timeframes requested, as its financial accounting and reporting year runs from April to March. It can confirm that G4S Health UK received £4.05 million between 1 April 2020 and 31 March 2021, and £2.495 million between 1 April 2021 to 31 March 2022 for health care in the detained estate. No payments were made to Mountain Healthcare during these periods.
Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much NHS England paid for the provision of sexual assault referral services in the financial years (a) 2020-21, (b) 2021-22 and (c) 2022-23.
Answered by Maria Caulfield
The following table shows the amounts paid by NHS England for the provision of Sexual Assault and Abuse Services over the past three financial years:
Financial Year | Amount (£) |
2020/21 | 38,998,000 |
2021/22 | 42,331,000 |
2022/23 | 48,090,000 |
Source: NHS England
Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much NHS England paid for the provision of sexual assault referral services to (a) Mountain Healthcare Ltd and (b) G4S Health UK Ltd between (i) October 2020 to September 2021 and (ii) October 2021 to September 2022.
Answered by Maria Caulfield
The information is not held in the format requested as NHS England's financial accounting and reporting is from April to March. The following table shows the amounts paid to both Mountain Healthcare Ltd and G4S Health UK Ltd over the past three financial years, for the provision of sexual assault referral services:
Financial Year | Amount paid to Mountain Healthcare Ltd (£) | Amount paid to G4S Health UK Ltd (£) |
2020/21 | 4,431,000 | 4,406,000 |
2021/22 | 8,073,000 | 4,124,000 |
2022/23 | 10,911,000 | 5,076,000 |
Source: NHS England
Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much his Department spent on the (a) Childcare Allowance (b) Parent Learning Allowance and (c) Dependent's Allowance of the NHS Bursary; and how many people have (i) made a claim and (ii) been eligible for support under that scheme in each of the last five years.
Answered by Will Quince
Prior to 2017, the NHS Bursary was available to nursing, midwifery and allied health professions students as well as medical and dental students. Nursing, midwifery and allied health professions students starting courses after 2017 were transitioned on to the Student Finance loans system and the NHS Learning Support Fund.
The following table shows for the years 2018/19 to 2022/23 the number of students who received an element of NHS Bursary, together with the number of students who received available childcare components and their corresponding expenditure.
Financial Year | 2018/19 | 2019/20 | 2020/21 | 2021/22 | 2022/23* |
Number of Students who Received an Element of Funding | 67,748 | 43,470 | 20,147 | 17,289 | 18,076 |
Number of Students in Receipt of Dependants Allowance | 9,178 | 5,050 | 1,096 | 357 | 247 |
Dependants Allowance Expenditure (£) | 19,053,850 | 8,344,526 | 1,599,887 | 539,752 | 363,775 |
Number of Students in Receipt of Parent Learning Allowance | 9,141 | 5,033 | 1,077 | 332 | 179 |
Parent Learning Allowance Expenditure (£) | 7,846,287 | 3,417,731 | 653,253 | 211,489 | 103,489 |
Number of Students in Receipt of Childcare Allowance | 5,031 | 2,557 | 576 | 144 | 83 |
Childcare Allowance Expenditure (£) | 16,659,222 | 7,028,750 | 1,313,955 | 399,834 | 238,972 |
Source: NHS Business Services Authority
Note: The NHS Business Services Authority moved to a new system in 2022/23. The student count is from two different IT systems with no unique identifier, with potential for duplication in the count. Financial values are unaffected.
Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what stocks NHS England has of (a) covid-19 boosters, (b) covid-19 rapid tests, (c) N95 masks and (d) flu vaccines as of October 2023, in the context of preparations for winter 2023-24.
Answered by Maria Caulfield
COVID-19 vaccines are purchased by the UK Health Security Agency (UKHSA). NHS England manages the distribution of stock to the front-line. At the beginning of the autumn/winter campaign, NHS England had access to 14.5 million doses of applicable vaccines, to meet the needs of the eligible cohorts as advised by the Joint Committee on Vaccination and Immunisation. NHS England also has stocks of 1,509,200 COVID-19 rapid tests and 114,061,080 FFP3 respirators.
NHS England does not centrally procure or stock any adult flu vaccines. General practitioners and other providers are responsible for ordering adult flu vaccine directly from suppliers, which are used to deliver the national flu programme to the other eligible groups.
Children’s flu vaccines are centrally procured and distributed by UKHSA. We are unable to provide specific stack levels as this information is commercially sensitive but there are adequate stocks of the live attenuated vaccine.